Skip to main content
Premium Trial:

Request an Annual Quote

U of Edinburgh Licenses Genotyping Technology from KeyGene

NEW YORK (GenomeWeb) – KeyGene today announced it has licensed its sequencing-based genotyping technology to the University of Edinburgh for research purposes.

The license includes access to and use of KeyGene's restricted-site associated DNA sequencing technology. The SBG technology enables the discovery and scoring of genetic variation for improving crops without prior knowledge of the genome sequence and provides researchers with a method to conduct genome-wide SNP discovery and genotyping in a single experiment, KeyGene said.

Financial and other terms of the deal were not disclosed.

"With this license and the support of KeyGene, we will be able to drive further discoveries in crop, animal, and environmental science," Edinburgh Genomics Director Mark Blaxter said in a statement. The genomics and bioinformatics facility is based at the University of Edinburgh.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.